Congenica Appoints Wendy Britten as CFOCongenica today announced the appointment of Mrs Wendy Britten as its new Chief Financial Officer (CFO), effective 1st September, 2018. Mrs Britten will have overall control and responsibility for all … more ➔
Greg Rush joins Parexel as Executive VP...Parexel International Corporation today announced the appointment of Greg Rush as Executive Vice President and Chief Financial Officer. more ➔
Zelluna appoints Dr. Namir HassanZelluna Immunotherapy, a biotechnology company specializing in T-cell receptor (TCR) immunotherapies, has announced the appointment of Dr. Namir Hassan as chief scientific officer (CSO). more ➔
Novartis names Klaus Moosmayer as Chief...Novartis announced today the appointment of Dr Klaus Moosmayer as Chief Ethics, Risk and Compliance Officer. He will report to Vas Narasimhan, M.D., CEO of Novartis and become a member of the Executive … more ➔
Sphere Fluidics appoints Dr Tris VaughanSphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, announced today that Tris Vaughan, PhD FRSB has joined its scientific advisory board … more ➔
Cellectis Appoints Stefan SchererCellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited allogeneic CAR T-cells (UCART), announced today the appointment of Dr. Stefan Scherer, … more ➔
Cell Medica Appoints New CEOCell Medica, a company active in the development, manufacture and marketing of personalised cellular immunotherapeutics for the treatment of cancer, has appointed Chris Nowers as Chief Executive Officer … more ➔
Marinomed Biotech Appoints New CFOPascal Schmidt appointed CFO as Vienna based biotech firm Marinomedas of August 1 2018. more ➔
Morphosys launches US subsidiary, appoin...Morphosys has named Jennifer Herron President of MorphoSys US Inc. to build up sales presence overseas. more ➔
Lundbeck names new president and CEOThe Board of Directors of the company has appointed Dr. Deborah Dunsire as new president and CEO of Lundbeck. Deborah Dunsire will take up her new position on 1 September 2018. more ➔
